World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
42904
World Ranking
11559
National Ranking
431

Overview

Sergio Amadori is affiliated with the University of Rome Tor Vergata in Italy and focuses primarily on research in medicine with an emphasis on hematology. Their academic work includes exploration of genetics, public health, environmental and occupational health, molecular biology, and cancer research.

The scientist's research concentrates on a range of topics within hematology, especially acute myeloid leukemia and other leukemia-related fields. Main topics covered in their work include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Cancer Genomics and Diagnostics
  • Hematopoietic Stem Cell Transplantation
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Amadori has published extensively in various peer-reviewed journals. Frequent publication venues comprise:

  • Clinical Lymphoma Myeloma & Leukemia
  • Blood
  • HemaSphere
  • Leukemia
  • Blood Advances

Several recent papers include the following works:

  • Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial, 2023, The Lancet
  • Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial, 2021, Leukemia
  • Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results, 2021, Leukemia
  • Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial, 2020, Blood Advances
  • Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study, 2020, The Lancet Haematology

Amadori collaborates regularly with a number of researchers in the field. Frequent co-authors include:

  • Richard F. Schlenk
  • Hervé Dombret
  • Pau Montesinos
  • Harry P. Erba
  • Elżbieta Patkowska

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura

    Roberto Stasi;Adalberto Pagano;Elisa Stipa;Sergio Amadori

  • Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

    Giampaolo Bucaneve;Alessandra Micozzi;Francesco Menichetti;Pietro Martino

  • Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.

    Francois Guilhot;Jane Apperley;Dong-Wook Kim;Eduardo O. Bullorsky

  • Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

    Eliane Gluckman;Vanderson Rocha;William Arcese;Gérard Michel

  • Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

    Stefan Suciu;Franco Mandelli;Theo de Witte;Robert Zittoun

  • Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab

    Roberto Stasi;Nichola Cooper;Giovanni Del Poeta;Elisa Stipa

  • Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpura**

    Roberto Stasi;Elisa Stipa;Mario Masi;Manrico Cecconi

  • Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Mark Levis;Farhad Ravandi;Eunice S. Wang;Maria R. Baer

  • Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)

    Giovanni Del Poeta;Adriano Venditti;Maria Ilaria Del Principe;Luca Maurillo

  • Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

    Luciana Annino;Maria Luce Vegna;Andrea Camera;Giorgina Specchia

  • Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

    Roberto Stasi;Ameet Sarpatwari;Jodi B. Segal;John Osborn

  • The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

    Nichola Cooper;Roberto Stasi;Susanna Cunningham-Rundles;Michael A. Feuerstein

  • Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

    Uwe Platzbecker;Giuseppe Avvisati;Laura Cicconi;Christian Thiede

  • Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

    Mandelli F;Avvisati G;Amadori S;Boccadoro M

  • IKZF1 (Ikaros) Deletions in BCR-ABL1–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

    Giovanni Martinelli;Ilaria Iacobucci;Clelia Tiziana Storlazzi;Marco Vignetti

  • Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management

    Roberto Stasi;Maria Laura Evangelista;Elisa Stipa;Francesco Buccisano

Frequent Co-Authors

Franco Mandelli
Franco Mandelli Sapienza University of Rome
Francesco Lo-Coco
Francesco Lo-Coco University of Rome Tor Vergata
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Valter Gattei
Valter Gattei University of Trieste
Theo de Witte
Theo de Witte Radboud University
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg
Hartmut Döhner
Hartmut Döhner University of Ulm
William Arcese
William Arcese Sapienza University of Rome
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Giorgina Specchia
Giorgina Specchia University of Bari Aldo Moro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a wide variety of rewarding online degrees and healthcare career paths. Many students begin their journey through flexible programs that don’t require extensive entry testing. For example, you can start your nursing career by enrolling in an lpn program no entrance exam, providing an accessible route to licensed practical nursing.

If you're interested in leadership roles, consider a health care administration degree online. This option is ideal for those aiming to manage healthcare facilities or oversee medical operations without transitioning to clinical work.

Nurses aiming to advance their education can choose an adn to np bridge program, moving efficiently from an associate degree in nursing to nurse practitioner status. These programs help registered nurses step into advanced practice roles without starting from scratch.

Additionally, students seeking to specialize in wellness and patient education may benefit from an online degree in nutrition. This pathway prepares graduates for roles in clinical nutrition, dietetics, or health policy, supporting holistic patient care.

Best Scientists Citing Sergio Amadori

Trending Scientists